NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
37 hedge funds and large institutions have $15.9M invested in InVivo Therapeutics Holdings Corp in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
91% less call options, than puts
Call options by funds: $11K | Put options by funds: $117K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holding in Top 10
–
Calls
$11K
Puts
$117K
Top Buyers
| 1 | +$1.31M | |
| 2 | +$1.09M | |
| 3 | +$434K | |
| 4 |
ECM
Element Capital Management
New York
|
+$368K |
| 5 |
Goldman Sachs
New York
|
+$251K |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$987K | |
| 3 | -$805K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$562K |
| 5 |
Bank of New York Mellon
New York
|
-$420K |